TFPI and neoplasm: Heparanase also interacts with tissue factor pathway inhibitor (TFPI) on the cell surface, leading to dissociation of TFPI from the cell membrane of endothelial and tumor cells, resulting in decreased anticoagulant capacity at the cell surface [9].